Ridhi Synthetic Traders Board of Directors

Get the latest insights into the leadership at Ridhi Synthetic Traders. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Vishal Chaturvedi Whole Time Director
Ms. Deepa Rupesh Bhavsar Non Exe.Non Ind.Director
Mr. Jash Dalia Ind. Non-Executive Director
Mr. Prateek Parag Parekh Ind. Non-Executive Director

Ridhi Synthetic Traders Share price

RIDHISYN

4.11

0.00 (0.00%)
Last updated on 30 Sep, 2025 | 16:00 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

0.00

52 Week High

0.00

The current prices are delayed, login to your account for live prices

Ridhi Synthetic Traders FAQs

The board at Ridhi Synthetic Traders consists of experienced professionals, including Mr. Vishal Chaturvedi , Ms. Deepa Rupesh Bhavsar , and others, overseeing the company’s strategic and corporate governance.

Directors at Ridhi Synthetic Traders are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Vishal Chaturvedi is the current chairman at Ridhi Synthetic Traders.

Executive directors at Ridhi Synthetic Traders are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Ridhi Synthetic Traders adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Ridhi Synthetic Traders, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.